The Saudi government has invested heavily in healthcare and we, as an industry, consider it to be a strategic market in which most of Mecomed's companies…
In Conversation
The future is rosy. [Saudi Arabia] has good capabilities, the economy is growing, and the people are young, energetic, and well educated
Biopharmaceutical companies have a big role to play in advancing innovation for health and driving collaborations to deliver better healthcare outcomes.
The fact that Novo Nordisk in Saudi Arabia has been ranked as the No.1 ‘Best Places to Work’ for the last three years and ranked No.1…
The general manager for Recordati Rare Diseases in MENA, Tony Zbeidy, explains why awareness of rare disorders has vastly improved in the region, which has one…
Ali Yehia, Country Manager for Viatris KSA, speaks about the company’s global operations and its plans for KSA, notably to play an active role in the…
Sanofi has been quick in the registration process thanks to its fantastic regulatory affairs department and has been able to launch products for multiple myeloma, different…
As a country, Saudi Arabia wants to match the well-established regulatory systems of North America, Europe, and Japan, but adding a halal component, which is of…
Today, international companies can see the value and the benefit of collaborating with Saudi businesses due to societal changes and government support
We are opening a new chapter in medicine. The early 2000s were focused on monoclonal antibodies, 2015 to 2025 is all about immune therapy, but 2025…
I really care about having operational people on the ground because, in the generics business, if you are not fast, you lose
Vision 2030 is a big opportunity, a north star that challenges each one of us to bring our best and contribute to Saudi Arabia's future
